Markus Warmuth

Insider Reports History

Entity
Individual
Location
Monte Rosa Therapeutics, Inc., 40 Guest Street, Boston, MA
Signature
/s/ Markus Warmuth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Markus Warmuth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 346K Jan 2, 2024 Direct

Insider Reports Filed by Markus Warmuth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 President & CEO, Director
GLUE Monte Rosa Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 President & CEO, Director
GLUE Monte Rosa Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 2, 2022 President & CEO, Director
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 President & Chief Executive Officer Exhibit 24 - Power of Attorney, Director
GLUE Monte Rosa Therapeutics, Inc. Apr 12, 2021 2 $0 4 Jun 25, 2021 President & Chief Executive Officer, Director